TITAN PHARMACEUTICALS INC 4
4 · TITAN PHARMACEUTICALS INC · Filed Feb 22, 2016
Insider Transaction Report
Form 4
BHONSLE SUNIL
DirectorPresident
Transactions
- Purchase
Common Stock
2016-02-22$3.56/sh+11,763$41,817→ 125,578 total
Holdings
- 54,684(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $3.50 to $3.61. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]The reporting person serves as trustee of the family trust.